| CENTESSA PHARMACEUTICALS |
| USA |
| Gesundheit |
| US1523091007 / A3CQ72 |
| 260 (Frankfurt) / CNTA (NASDAQ) |
| FRA:260, ETR:260, 260:GR, NASDAQ:CNTA |
| - |
| https://centessa.com/ |
|
Centessa Pharmaceuticals plc - ADR is a type of fi..
>Volltext.. |
| 3112.01 Mio. EUR |
| 3003.03 Mio. EUR |
| 12.83 Mio. EUR |
| -181.12 Mio. EUR |
| -206.16 Mio. EUR |
| -1.55 EUR |
| 100.73 Mio. EUR |
| 43.28 Mio. EUR |
| -154.1 Mio. EUR |
| 8.45 |
| 117.83% |
| -49.36% |
| - |
| - |
| - |
| CENTESSA |
| 15.12.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|